Literature DB >> 3745425

Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

W H Gerlich, A Uy, F Lambrecht, R Thomssen.   

Abstract

The titer of antibody against core antigen of hepatitis B virus in the immunoglobulin M class (IgM anti-HBc) was determined by an IgM capture assay of reduced sensitivity (30 arbitrary units). The distribution of titers among 235 acute hepatitis patients who were hepatitis B surface antigen (HBsAg) positive suggested that 600 U forms a lower cutoff value for acute hepatitis B. Clinically apparent cases of acute hepatitis with high IgM anti-HBc and without HBsAg were rare (2.6%). Acute, non-B hepatitis in HBsAg carriers was more frequent (9.4%). In chronic hepatitis B, 39% of 174 biopsy-proven cases had moderate titers of 30 to 600 U, whereas healthy HBsAg carriers were rarely (4/84) positive. In mild or inapparent infections without HBsAg, titers were between 50 and 400 U. Thus, sufficiently accurate and sensitive quantitation of IgM anti-HBc allows for differentiation of acute and nonacute hepatitis B virus infection in acute hepatitis, partial differentiation between clinically symptomatic and asymptomatic chronic infections, and identification of recent subclinical infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745425      PMCID: PMC268891          DOI: 10.1128/jcm.24.2.288-293.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.

Authors:  H H Dromeyer; W Arnold; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

2.  Anti-HBc titers and anti-HBc immunoglobulin (M/G) classes in acute, chronic and resolved hepatitis B.

Authors:  P Niermeijer; C H Gips; J R Huizenga; H J Houthoff; J A Snijder
Journal:  Hepatogastroenterology       Date:  1980-08

3.  The diagnostical significance of antibodies against hepatitis B core antigen.

Authors:  W H Gerlich; R M Biswas; B Stamm; R Thomssen
Journal:  Klin Wochenschr       Date:  1977-11-01

4.  Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection.

Authors:  M Roggendorf; F Deinhardt; G G Frösner; R Scheid; B Bayerl; R Zachoval
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

5.  Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen.

Authors:  W H Gerlich; W Lüer; R Thomssen
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

6.  Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.

Authors:  M Sjogren; J H Hoofnagle
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

7.  Significance of persisting IgM anti-HBc antibodies in hepatitis B virus infection.

Authors:  R Cappel; D Van Beers; F Maes; M Toppet; S Cadranel
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

8.  Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay.

Authors:  W H Gerlich; W Lüer
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

9.  IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus.

Authors:  S M Lemon; N L Gates; T E Simms; W H Bancroft
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

10.  IgM-antibody response to the hepatitis B core antigen in acute and chronic hepatitis B.

Authors:  R S Tedder; R Wilson-Croome
Journal:  J Hyg (Lond)       Date:  1981-04
View more
  20 in total

1.  Sensitivity of anti-HBc IgM kits and the diagnosis of acute hepatitis B.

Authors:  J A Diment
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

2.  Outbreak of hepatitis B in a nursing home associated with capillary blood sampling.

Authors:  J M Dreesman; A Baillot; L Hamschmidt; M Monazahian; U C Wend; W H Gerlich
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

3.  Diagnosis of acute hepatitis B by qualitative assay of specific IgM antibody.

Authors:  D J Morris
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

4.  Performance characteristics of microparticle enzyme and chemiluminescence immunoassays for measurement of anti-HBc immunoglobulin M in sera of patients with HBeAg-negative chronic hepatitis B virus infection.

Authors:  Emilia Hadziyannis; Emanuel Manesis; Dimitrios Vassilopoulos; Anastasia Georgiou; Athanasios Archimandritis
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

5.  Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.

Authors:  T Cao; U Lazdina; I Desombere; P Vanlandschoot; D R Milich; M Sällberg; G Leroux-Roels
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 6.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

Review 7.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections.

Authors:  J Hess; M Stemler; H Will; C H Schröder; J Kühn; R Braun
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

Review 9.  Diagnostic markers of viral hepatitis B and C.

Authors:  C Trépo; F Zoulim; C Alonso; M A Petit; C Pichoud; L Vitvitski
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Problems in diagnosing viral hepatitis.

Authors:  F Bonino; G Colloredo Mels; G Bellati; G Ideo; F Oliveri; P Colombatto; M R Brunetto
Journal:  Gut       Date:  1993       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.